Cell-based assays demonstrate reduced secretion of WNT3A in the presence of mutant PORCN. These combined findings support that defective Wnt signaling is at the basis of the phenotypic features of FDH. The gene discussed is WNT3A; the disease is focal dermal hypoplasia.